Oral Oncology Symposium
MD Anderson Cancer Center is closely following the impact of COVID-19 on global populations and travel. At this time, out of an abundance of caution, we regret to inform you all educational activities through April 29th are being postponed. Your health and safety, and that of our patients and employees, is our highest priority.
May 14-16, 2020
The University of Texas MD Anderson Cancer Center
Robert C. Hickey Auditorium
Floor 11, R. Lee Clark Clinic
1515 Holcombe Blvd.
Houston, TX 77030
Conf. #: D122078
16.75 AMA PRA Category 1 Credits™
This conference should be of value to dentists, otolaryngologists, nurses, dental/otolaryngology fellows, residents, dental and medical staff.
Agendas are subject to change because we are always striving to improve the quality of your educational experience. MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness and/or scheduling conflicts, conflicts and so forth.
Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in this activity.
Fax CME/Conference Management at 713-794-1724 or email firstname.lastname@example.org. All responses will be forwarded to the Program Chair for consideration.
The goal of this symposium is to improve recognition, which will lead to early detection and improve outcomes. Improved management of cancer related symptoms can lead to improved treatment compliance, patient comfort and quality of life.
This Symposium is intended for healthcare professionals. These individuals are in a unique situation where they can detect oral and head and neck cancers. Dentists often have limited experience in diagnosing head and neck malignancies or detecting the signs. Also, dental professions are typically untrained and apprehensive about dental treatment for patients with cancer. Currently, many dental practices are focused on cosmetics and esthetics. This Symposium will redirect their focus and enhance their knowledge on detection, treatment, and management of the cancer patient. The Symposium aims to improve the recognition of the presenting signs of head and neck cancer, and encourage timely referrals for biopsy and treatment. It will also teach the dentists to improve the management of oral symptoms related to multiple cancer therapies, and be aware of the difficulties that treatment may create.
After attending this Symposium, participants should be able to:
- Identify fundamentals of major therapies for head and neck cancer (Knowledge)
- Evaluate head and neck cancer patients with a complete oral diagnostic and radiographic workup, resulting in early diagnosis and more appropriate treatment (Knowledge, Competence, Performance, Patient Outcomes)
- Discuss key issues with the patient’s oncology team to ensure both local and systemic control of symptoms (Knowledge, Competence, Performance, Patient Outcomes)
- Define and implement a “multidisciplinary approach” in the treatment of head and neck cancer patients to improve dental management in the oncology patient (Knowledge, Competence, Performance, Patient Outcomes)
- Identify and implement management strategies of primary oral sequela and secondary mucosal disorders of cancer therapy, which will result in improved treatment, compliance, patient comfort and quality of life (Knowledge, Competence, Performance, Patient Outcomes)
- Summarize the phases of prosthetic rehabilitation of the head and neck cancer patient and recognize key elements of fabricating maxillofacial prostheses (Knowledge)
- Facilitate speech, swallowing, functional rehabilitation and nutritional counseling in head and neck cancer patients, resulting in improved functional outcomes (Knowledge, Competence, Performance, Patient Outcomes); and
- Evaluate and treat infectious complications in cancer patients and manage the pain and symptoms, improving patient comfort and quality of life (Knowledge, Competence, Performance, Patient Outcomes).
- Questions and Answers Session
- Case Presentations
- Panel Discussions
- Posters Session and Presentations
A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Texas MD Anderson Cancer Center and The University of Texas Health Science Center at Houston School of Dentistry. The University of Texas MD Anderson Cancer Center name of accredited provider is accredited by the ACCME to provide continuing medical education for physicians.
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 16.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Recognition Program (ADA CERP) through joint efforts between The University of Texas School of Dentistry at Houston - PACE Center, Continuing Dental Education and The University of Texas MD Anderson Cancer Center Department of CME/Conference Management.
Attendance at didactic sessions can earn a maximum of 16.5 credit hours in AGD Codes: 070 Endodontics, 158 Tobacco Cessation, 310 Oral and Maxillofacial Surgery, 670 Prosthodontics/Removable, 690 Implants and 730 Oral Medicine, Oral Diagnosis, Oral Pathology.
The formal continuing education programs of this sponsor are accepted by AGD for Fellowship/Mastership credit. The current term of acceptance extends from 11/01/2015 to 12/31/2019. The University of Texas School of Dentistry at Houston is a member of the Association for Continuing Dental Education.
The University of Texas MD Anderson Cancer Center is an approved provider with distinction of nursing continuing professional development by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Nurses will be awarded up to 14.75 CNE contact hours when requirements for successful completion are met. Nurses must arrive and sign-in no later than 15 minutes after the first session begins and full participation must occur. Nurses must complete an online evaluation that will only be open for 7 consecutive days at the close of the educational activity. A “Certificate of Successful Completion” will be electronically emailed to the address provided.
CME Certificates and Attendance Verification Certificates
Certificates awarding AMA PRA Category 1 Credit™ or certificates documenting attendance will be distributed to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form.
Upon request, a record of attendance (certificate) will be provided on-site to other healthcare professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.
The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.
Physician Payments Sunshine Act
MD Anderson complies with the Physician Payments Sunshine Act as part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfer of value provided to any covered recipient under the ACA.
DEADLINE FOR ABSTRACT SUBMISSIONS IS - Tuesday, March 31, 2020.
Submit abstracts for poster presentation to: email@example.com
Oral Oncology, Maxillofacial Prosthetics, Oral Medicine, and Oral Cancer Research are acceptable. All abstract submitters should be prepared to present their work as a poster.
Abstract Formatting Instructions:
- Limit poster abstracts to one page, typed single-spaced on plain 8.5 x 11 inch paper.
- Organize the abstract into Purpose, Methods, Results, and Conclusions. All abbreviations or acronyms should be spelled out the first time they are used.
- Provide three to five keywords describing the nature and content of the abstract.
- Please include the name of the conference, title of your presentation, author’s full name, highest degree, and institutional affiliation. Also please include author’s telephone, fax, and email information.
Registration for the conference must be submitted at the same time as the abstract. Register at www.mdanderson.org/conferences.
Abstract and Poster Notification Dates:
The conference committee will select abstracts for poster presentations based on the scientific merit and the quality of the content. Abstracts that are not submitted in the format above will not be accepted. Abstracts will not be edited.
The first author of the abstract will receive an email by Monday, April 6, 2020 confirming that the abstract was received. Notification of acceptance for poster presentations with directives and poster size will be acknowledged by Monday, April 20, 2020 via email.
Freestanding 4 ft. x 8 ft. display boards and pushpins will be provided for the poster session. An award for the best two posters will be presented.
The information contained in this e-mail message may be privileged, confidential, and/or protected from disclosure. This e-mail message may contain protected health information (PHI); dissemination of PHI should comply with applicable federal and state laws. If you are not the intended recipient, or an authorized representative of the intended recipient, any further review, disclosure, use, dissemination, distribution, or copying of this message or any attachment (or the information contained therein) is strictly prohibited. If you think that you have received this e-mail message in error, please notify the sender by return e-mail and delete all references to it and its contents from
On-site registration opens at 7:30 am on Thursday, May 14, 2020 at MD Anderson Cancer Center, Clark Clinic, Hickey Auditorium, 1515 Holcombe Boulevard, Houston, Texas. The opening session of the conference will begin at 8:00 am on Thursday, May 14, 2020 and the conference will adjourn at 12:00 pm on Saturday, May 16, 2020.
Advanced registration is encouraged as space and materials are limited. Please see the registration form for applicable fees.
The deadline for advanced registration is Friday, April 24, 2020.
Postmarked before April 24, 2020
- Physicians/Dentists: $500.00
- Nurses/Hygienists/Dental Assistants: $300.00
- Students/Fellows/Residents: $220.00
- UT Nurses/Hygienists/Dental Assistants: $300.00
- MD Anderson Faculty/Staff: $200.00
- MD Anderson Students/Fellows/Residents: $190.00
Postmarked After April 24, 2020
- Physicians/Dentists: $550.00
- Nurses/Hygienists/Dental Assistants: $350.00
- Students/Fellows/Residents: $250.00
- UT Nurses/Hygienists/Dental Assistants: $350.00
- MD Anderson Faculty/Staff: $200.00
- MD Anderson Students/Fellows/Residents: $190.00
Registration On-line (Above): you may experience intermittent problems with creating new profile accounts for new registrations. If a problem does occur, please feel free to click the Printable Form (Below) and fax to our offices 713-794-1724. Please note the fax machine is located in a secured vault room.
There are two other ways to register:
CME/Conference Management, Unit 1781
The University of Texas MD Anderson Cancer Center
P.O. Box 301407
Houston, TX 77230-1707
Fax to: 713-794-1724 (Printable Form)
We accept the following forms of payment:
- Check (payable through U.S. banks only)
- Money order
- Credit cards (MasterCard, VISA and American Express)
- Cash (on-site registration only)
If you register online, a receipt/confirmation letter will beautomatically emailed to the email address you list on the registration form. If you register by fax or mail, a receipt/confirmation letter will be sent to you within 10 working days of the receipt of your fee.
The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before Friday, April, 24, 2020. No refunds will be granted after that date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. For additional information, contact CME/Conference Management at 713-792-2223 or toll free at 866-849-5866 or you may email firstname.lastname@example.org.
The Department of CME/Conference Management reserves the right to cancel activities prior to the scheduled date if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, email or at the phone or fax numbers given on the registration form.
In case of activity cancellation, the liability of the Department of CME/Conference Management is limited to the registration fee. CME/Conference Management will refund the full registration fee.
The Department of CME/Conference Management reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.
- A block of rooms has been reserved for conference attendees at Houston Marriott Medical Center Hotel, 6580 Fannin Street, Houston, Texas.
- Early reservation is suggested.
- The hotel phone number is 713-796-0080. The toll free number is 1-800-228-9290.
- When you make reservations be sure to mention the “MD Anderson/Oral Oncology Symposium” to be assured of receiving the special meeting rate of $129.00 single or double occupancy. Please add 17% Texas state and local taxes.
- Room Reservation Website: Book your group rate for Book your group rate for MD Anderson Oral Oncology Symposium Room Block or https://bit.ly/2rI8dkc
- Reservations and deposits received after Tuesday, April 28, 2020, will be confirmed if space is available and at currently published hotel guest room rates.
Prices are subject to change and vary depending on the location of the conference.
- Houston is served by two airports, George Bush Intercontinental (IAH) and William P.Hobby (HOU).
- The following ground transportations are available to and from the airports
- Uber and Lyft
- Yellow Cab 713-236-1111
- Fiesta Cab 713-225-2666.
Parking is available in Garage 10, which is located on the east side of the Clark Clinic, for $12 per day. There are EasyPay Stations on the first, second and third floors, instead of a cashier. The EasyPay Station is a self-serve payment station and will take cash or credit cards. You feed your ticket into the machine, it tells you how much you owe, you then pay that amount and the machine returns your "paid" ticket. Take the "paid" ticket to the exit gate and feed it into a machine there to raise the gate and exit the garage.
Take the crosswalk on level 3 of Garage 10 into MD Anderson. The first set of elevators on your left (next to the guard station) can be used to access floor 11. As you exit the elevator on floor 11, you will be at the back of the auditorium. Turn to your left to follow the hallway to the registration desk and the front of the auditorium.
Click here for a map.
Parking fees are not reimbursable.
Photographing, audio taping and video taping are prohibited.